Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,300 | 9 | 41.3% |
| Food and Beverage | $10,321 | 481 | 32.1% |
| Consulting Fee | $5,100 | 8 | 15.8% |
| Travel and Lodging | $3,371 | 14 | 10.5% |
| Education | $87.90 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $24,433 | 145 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,251 | 58 | $0 (2024) |
| Lilly USA, LLC | $842.80 | 53 | $0 (2024) |
| Amgen Inc. | $541.35 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $429.05 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $376.98 | 37 | $0 (2023) |
| Novo Nordisk Inc | $355.76 | 25 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $291.17 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $260.55 | 22 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $215.83 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,807 | 69 | ABBVIE INC. ($2,290) |
| 2023 | $9,450 | 126 | ABBVIE INC. ($7,177) |
| 2022 | $11,389 | 123 | ABBVIE INC. ($9,847) |
| 2021 | $7,534 | 199 | AbbVie Inc. ($5,120) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $10.90 | General |
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 09/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $121.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: PAIN | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 627 | 904 | $97,244 | $39,015 |
| 2022 | 13 | 699 | 1,150 | $99,164 | $42,299 |
| 2021 | 18 | 984 | 1,691 | $136,339 | $59,524 |
| 2020 | 18 | 1,132 | 1,646 | $140,587 | $60,660 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 239 | $40,220 | $14,990 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $16,439 | $9,315 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 189 | $23,195 | $8,366 | 36.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 141 | 182 | $1,684 | $1,422 | 84.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,830 | $1,176 | 24.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $932.00 | $910.28 | 97.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 25 | 25 | $675.00 | $635.04 | 94.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,440 | $530.52 | 36.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 13 | $650.00 | $527.15 | 81.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 58 | $5,510 | $523.60 | 9.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $341.00 | $314.93 | 92.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 11 | $920.00 | $267.57 | 29.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 17 | $408.00 | $37.40 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 297 | $45,453 | $18,878 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $15,116 | $9,274 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 144 | $15,737 | $6,015 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $5,880 | $1,936 | 32.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,339 | $1,447 | 61.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,102 | $1,036 | 94.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 23 | $2,411 | $976.20 | 40.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 34 | 34 | $918.00 | $899.64 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 166 | 243 | $1,969 | $706.43 | 35.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 57 | $5,215 | $528.63 | 10.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $482.00 | $438.84 | 91.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 140 | $1,864 | $98.60 | 5.3% |
About Christopher Lambert
Christopher Lambert is a Family healthcare provider based in Bloomington, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063801983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Lambert has received a total of $32,180 in payments from pharmaceutical and medical device companies, with $3,807 received in 2024. These payments were reported across 517 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,300).
As a Medicare-enrolled provider, Lambert has provided services to 3,442 Medicare beneficiaries, totaling 5,391 services with total Medicare billing of $201,498. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Bloomington, IN
- Active Since 01/15/2015
- Last Updated 03/21/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1063801983
Products in Payments
- VRAYLAR (Drug) $17,584
- FARXIGA (Drug) $813.47
- BREZTRI (Drug) $742.67
- UBRELVY (Drug) $591.19
- TEZSPIRE (Biological) $387.85
- NURTEC ODT (Drug) $344.36
- AIRSUPRA (Drug) $320.77
- QUVIVIQ (Drug) $291.17
- EMGALITY (Drug) $288.25
- QULIPTA (Drug) $268.05
- TRELEGY ELLIPTA (Drug) $260.28
- ENTRESTO (Drug) $254.47
- TRINTELLIX (Drug) $253.32
- JARDIANCE (Drug) $231.27
- Otezla (Drug) $220.72
- VOQUEZNA (Drug) $206.59
- OPZELURA (Drug) $200.42
- LEQVIO (Drug) $174.58
- MOUNJARO (Drug) $166.50
- Aimovig (Biological) $150.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bloomington
Marcella Lindstrom, Aprn, Cnp, APRN, CNP
Family — Payments: $37,385
Brook Whitaker, Fnp-C, FNP-C
Family — Payments: $8,114
Courtney Mitchell, Np-C, NP-C
Family — Payments: $6,751
Angela Birdsell, Apn, APN
Family — Payments: $6,556
Laci Caudell, Np-C, NP-C
Family — Payments: $5,453
Elizabeth Igoe, Apn, APN
Family — Payments: $4,273